Endoscopic ultrasonography (EUS ) -guided fine needle aspiration (EUS -FNA ) of focal pancreatic lesions is an essential diagnostic procedure with high therapeutic effect in clinical routine. The aim of this study is to determine the levels of serum lipase, serum amylase and the tumor marker CA 19-9 prior and after EUS-FNA. In animal experiments on dogs, an increase of all three parameters was observed after surgery on the pancreas. For humans, these clinically important data are not yet available . It is assumed that the probability of pancreatitis with increased activity of lipase and amylase will rise with the number of puncture procedures as well as the size of the puncture needle. In addition, the post-interventional assessment of the tumor marker CA 19-9 could result in a false positive assumption of malignant neoplastic pancreatic lesion.
Study Type
OBSERVATIONAL
Enrollment
208
blood will be taken for assessment of serum lipase, serum amylase and CA 19-9 prior to EUS-FNA
During endoscopic ultrasonography, fine needle aspiration will be performed for cytological analysis of the pancreas
blood will be taken 4h after EUS-FNA for assessment of serum lipase, serum amylase and CA 19-9
Department of Gastroenterology, University Medical Center
Göttingen, Lower Saxony, Germany
RECRUITINGHELIOS Albert-Schweitzer Hospital Northeim
Northeim, Lower Saxony, Germany
RECRUITINGDepartment of Gastroenterology, Klinikum Bielefeld
Bielefeld, North Rhine-Westphalia, Germany
RECRUITINGSerum lipase
Time frame: up to 24h prior to EUS-FNA and 4 hours after EUS-FNA
Serum amylase
Time frame: up to 24 hours prior to EUS-FNA
Serum amylase
Time frame: 4 hours after EUS-FNA
CA 19-9
Time frame: up to 24 hours prior to EUS-FNA
CA 19-9
Time frame: 4 hours after EUS-FNA
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.